‹ Knowledge base
Browse the corpus
Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.
- 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review1 passage
- A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-41 passage
- A systematic review of how patients value COPD outcomes1 passage
- An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis1 passage
- Asthma and COVID-19 risk: a systematic review and meta-analysis1 passage
- Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis1 passage
- Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?1 passage
- Automated closed-loop versus standard manual oxygen administration after major abdominal or thoracic surgery: an international multicentre randomised controlled study1 passage
- Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma1 passage
- Best step-up treatments for children with uncontrolled asthma: a systematic review and network meta-analysis of individual participant data1 passage
- Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma1 passage
- Care in Chronic Obstructive Lung Disease (CAROL): a randomised trial in general practice1 passage
- Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis1 passage
- Effect of aerobic exercise training on asthma in adults: a systematic review and meta-analysis1 passage
- Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study1 passage
- Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)1 passage
- European Respiratory Society and American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia1 passage
- European Respiratory Society clinical practice guideline for the management of adult bronchiectasis1 passage
- European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia1 passage
- European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis1 passage
- Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review1 passage
- Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature1 passage
- Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results1 passage
- Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review1 passage
- Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline1 passage
- Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline1 passage
- Patient-reported outcome measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review1 passage
- Pharmacists and medication adherence in asthma: a systematic review and meta-analysis1 passage
- Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score1 passage
- Prognostic factors for development of acute respiratory distress syndrome following traumatic injury: a systematic review and meta-analysis1 passage
- Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses1 passage
- SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis1 passage
- Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension1 passage
- Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study1 passage
- Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)1 passage
- The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model1 passage
- Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma1 passage
- Tuberculosis in adult migrants in Europe: a TBnet consensus statement1 passage
- Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis1 passage